# Black Diamond Therapeutics, Inc.: filings

BDTX · Nasdaq · CIK 1701541 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bdtx.md) · [Financials](/companies/bdtx/financials.md) · [Filings](/companies/bdtx/filings.md) · [Insiders](/companies/bdtx/insiders.md)

## Reports and events: 107 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 247, 8-K 61, 3 35, 10-Q 20, 144 17, SC 13D/A 8, SC 13G 8, SC 13G/A 8, 10-K 7, S-8 7, CORRESP 6, DEF 14A 6, DEFA14A 6, ARS 4, D 4, SCHEDULE 13G/A 4, UPLOAD 4, DRS/A 3, EFFECT 3, SC 13D 3, 424B5 2, D/A 2, DRSLTR 2, S-3 2, SEC STAFF LETTER 2, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DRS 1, PRE 14A 1, S-1 1, S-1/A 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:04 ET | [10-Q](/filings/0001701541-26-000025.md) | Quarterly report, period 2026-06-30 | 0001701541-26-000025 |
| 2026-08-05 | 16:02 ET | [8-K](/filings/0001701541-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-26-000023 |
| 2026-06-29 | 16:20 ET | [8-K](/filings/0001104659-26-078847.md) | 5.07 Shareholder vote results | 0001104659-26-078847 |
| 2026-05-21 | 17:19 ET | [8-K](/filings/0001104659-26-065254.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065254 |
| 2026-05-07 | 07:20 ET | [10-Q](/filings/0001701541-26-000017.md) | Quarterly report, period 2026-03-31 | 0001701541-26-000017 |
| 2026-05-07 | 07:17 ET | [8-K](/filings/0001701541-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-26-000015 |
| 2026-04-29 | 16:03 ET | [DEF 14A](/filings/0001104659-26-051474.md) | Proxy statement, period 2026-06-26 | 0001104659-26-051474 |
| 2026-03-16 | 16:03 ET | [10-K](/filings/0001701541-26-000009.md) | Annual report, period 2025-12-31 | 0001701541-26-000009 |
| 2026-03-16 | 16:02 ET | [8-K](/filings/0001701541-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-26-000008 |
| 2025-12-03 | 08:20 ET | [8-K](/filings/0001104659-25-117975.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-117975 |
| 2025-11-06 | 07:12 ET | [10-Q](/filings/0001701541-25-000039.md) | Quarterly report, period 2025-09-30 | 0001701541-25-000039 |
| 2025-11-06 | 07:01 ET | [8-K](/filings/0001701541-25-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-25-000038 |
| 2025-08-07 | 07:04 ET | [10-Q](/filings/0001701541-25-000030.md) | Quarterly report, period 2025-06-30 | 0001701541-25-000030 |
| 2025-08-07 | 07:01 ET | [8-K](/filings/0001701541-25-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-25-000029 |
| 2025-06-12 | 16:19 ET | [8-K](/filings/0001104659-25-058893.md) | 5.07 Shareholder vote results | 0001104659-25-058893 |
| 2025-05-12 | 16:08 ET | [10-Q](/filings/0001701541-25-000022.md) | Quarterly report, period 2025-03-31 | 0001701541-25-000022 |
| 2025-05-12 | 16:06 ET | [8-K](/filings/0001701541-25-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-25-000021 |
| 2025-04-18 | 16:01 ET | [DEF 14A](/filings/0001104659-25-036339.md) | Proxy statement, period 2025-06-12 | 0001104659-25-036339 |
| 2025-03-19 | 07:08 ET | [8-K](/filings/0001104659-25-025338.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-025338 |
| 2025-03-06 | 16:03 ET | [10-K](/filings/0001701541-25-000016.md) | Annual report, period 2024-12-31 | 0001701541-25-000016 |
| 2025-03-06 | 16:01 ET | [8-K](/filings/0001701541-25-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-25-000014 |
| 2024-11-05 | 07:03 ET | [10-Q](/filings/0001701541-24-000042.md) | Quarterly report, period 2024-09-30 | 0001701541-24-000042 |
| 2024-11-05 | 07:01 ET | [8-K](/filings/0001701541-24-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-24-000040 |
| 2024-10-07 | 16:13 ET | [8-K](/filings/0001104659-24-106676.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-106676 |
| 2024-09-23 | 07:09 ET | [8-K](/filings/0001104659-24-101874.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-101874 |
| 2024-08-08 | 16:48 ET | [SC 13D/A](/filings/0001193125-24-197045.md) | Ownership report, active investor, amended | 0001193125-24-197045 |
| 2024-08-06 | 07:04 ET | [10-Q](/filings/0001701541-24-000030.md) | Quarterly report, period 2024-06-30 | 0001701541-24-000030 |
| 2024-08-06 | 07:00 ET | [8-K](/filings/0001701541-24-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-24-000028 |
| 2024-06-06 | 16:06 ET | [8-K](/filings/0001104659-24-069070.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-069070 |
| 2024-05-13 | 19:09 ET | [SC 13D/A](/filings/0001072613-24-000469.md) | Ownership report, active investor, amended | 0001072613-24-000469 |
| 2024-05-09 | 20:48 ET | [SC 13D/A](/filings/0001104659-24-059533.md) | Ownership report, active investor, amended | 0001104659-24-059533 |
| 2024-05-09 | 07:13 ET | [10-Q](/filings/0001701541-24-000022.md) | Quarterly report, period 2024-03-31 | 0001701541-24-000022 |
| 2024-05-09 | 07:10 ET | [8-K](/filings/0001701541-24-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-24-000020 |
| 2024-04-24 | 16:01 ET | [DEF 14A](/filings/0001104659-24-051211.md) | Proxy statement, period 2024-06-06 | 0001104659-24-051211 |
| 2024-04-11 | 08:03 ET | [8-K](/filings/0001104659-24-046096.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-046096 |
| 2024-03-12 | 07:20 ET | [10-K](/filings/0001701541-24-000011.md) | Annual report, period 2023-12-31 | 0001701541-24-000011 |
| 2024-03-12 | 07:17 ET | [8-K](/filings/0001701541-24-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-24-000009 |
| 2024-01-18 | 16:04 ET | [8-K](/filings/0001104659-24-004802.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-004802 |
| 2024-01-04 | 08:07 ET | [8-K](/filings/0001104659-24-001155.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-001155 |
| 2023-12-13 | 07:08 ET | [8-K](/filings/0001104659-23-125566.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-125566 |
| 2023-11-09 | 17:24 ET | [SC 13D/A](/filings/0001193125-23-274632.md) | Ownership report, active investor, amended | 0001193125-23-274632 |
| 2023-11-06 | 07:14 ET | [10-Q](/filings/0001701541-23-000047.md) | Quarterly report, period 2023-09-30 | 0001701541-23-000047 |
| 2023-11-06 | 07:10 ET | [8-K](/filings/0001701541-23-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-23-000045 |
| 2023-09-18 | 07:12 ET | [8-K](/filings/0001104659-23-101377.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-101377 |
| 2023-08-11 | 07:26 ET | [10-Q](/filings/0001701541-23-000041.md) | Quarterly report, period 2023-06-30 | 0001701541-23-000041 |
| 2023-08-11 | 07:22 ET | [8-K](/filings/0001701541-23-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-23-000039 |
| 2023-06-30 | 16:03 ET | [8-K](/filings/0001104659-23-077061.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-077061 |
| 2023-06-27 | 07:11 ET | [8-K](/filings/0001104659-23-074995.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-074995 |
| 2023-05-16 | 17:26 ET | [8-K](/filings/0001104659-23-061486.md) | 5.07 Shareholder vote results | 0001104659-23-061486 |
| 2023-05-09 | 07:45 ET | [10-Q](/filings/0001701541-23-000032.md) | Quarterly report, period 2023-03-31 | 0001701541-23-000032 |

Page 1 of 3. [Older](/companies/bdtx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.